# BRIEFING — 2026-09-04T08:43:00Z

## Mission
Investigate and formulate technical specification for Requirement R2: Portfolio Optimal Allocation & Execution Slippage / Friction Cost Minimization 5th Deepening (Features F37, F38).

## 🔒 My Identity
- Archetype: Teamwork explorer
- Roles: Read-only investigation, problem analysis, technical specification formulation, synthesis
- Working directory: d:\Finance\code\stock\.agents\explorer_survey_2
- Original parent: 61d3427d-726d-48df-945c-5ec75b30ebde
- Milestone: Phase 5 Deep Quantitative Enhancements Survey

## 🔒 Key Constraints
- Read-only investigation — do NOT implement
- Base investigation on authoritative files: ORIGINAL_REQUEST.md, PROJECT.md, handoff.md
- Deliver comprehensive report in analysis.md and summary in handoff.md
- Notify parent via send_message upon completion

## Current Parent
- Conversation ID: 61d3427d-726d-48df-945c-5ec75b30ebde
- Updated: not yet

## Investigation State
- **Explored paths**:
  * `src/risk/unified_portfolio_allocator.py`
  * `src/risk/portfolio_allocator.py`
  * `src/execution/smart_order_router.py`
  * `src/execution/oms_engine.py`
  * `src/execution/slippage_feedback.py`
  * `src/analysis/portfolio_optimizer.py`
  * `tests/test_phase4_portfolio_execution.py`
  * `tests/test_unified_portfolio_engine.py`
  * `tests/test_m2_portfolio_execution.py`
  * `tests/test_portfolio_allocator.py`
- **Key findings**:
  * Formulated Feature F37: Higher-order systematic co-skewness/co-kurtosis alpha and Cornish-Fisher CVaR tail penalty, Dynamic Risk Parity Diversification Ratio (DRP-DR) scaling ($\delta_{\text{DR}} \in [0.60, 1.40]$), Shannon entropy regime uncertainty volatility scaling, and Hill/Pickands GPD tail index estimation ($\hat{\xi} \in [0.05, 0.45]$).
  * Formulated Feature F38: Continuous Hawkes toxicity modulation ($\Gamma_{\text{toxic}} \in [0, 1]$), Darkpool MinQty ($\ge 20\%$) and queue-priority fill estimation, volatility- and depth-adaptive OBI curvature $\kappa(\sigma, R_{\text{depth}})$, ADV-adaptive Gatheral slice count $n_{\text{slices}}^*$ with intraday U-shaped volume smile $V_{\text{smile}}(t)$, and 5-market granular Leland buffer bands (KOSDAQ 35, KOSPI 25, Russell 16, NASDAQ 7, SP500 5 bps).
  * Outlined 18-case test architecture for `tests/test_phase5_portfolio_execution.py`.
- **Unexplored areas**:
  * None within R2 scope.

## Key Decisions Made
- Authored comprehensive architectural and mathematical report in `analysis.md`.
- Authored 5-component handoff in `handoff.md`.
- Maintained strict backward compatibility with existing tests.

## Artifact Index
- `DISPATCH.md` — initial dispatch message
- `BRIEFING.md` — persistent situational awareness
- `progress.md` — liveness heartbeat
- `analysis.md` — comprehensive technical specification and math formulations for F37 and F38
- `handoff.md` — 5-component handoff report
